Recruiting Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency NCT06090669 Conditions Bone Marrow Diseases, Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, +6 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
